Greenwich LifeSciences, Inc. (GLSI) stock
GLSINasdaqPharmaceutical PreparationsFiscal year ends December 31
$20.58+1.88 (+10.05%)
Close on Nov 18, 2026Market cap $302.08MP/E –Yield –
Greenwich LifeSciences market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Greenwich LifeSciences's market cap was $236.17M on Nov 11, 2026, against $120.43M a year earlier. Over the last 5 years it ranged from $100.24M to $414.80M, with a median of $170.09M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $236.17M | -18.5% |
| 2025 | Dec 31, 2025 | $289.82M | +96.3% |
| 2024 | Dec 31, 2024 | $147.61M | +9.2% |
| 2023 | Dec 29, 2023 | $135.16M | -30.8% |
| 2022 | Dec 30, 2022 | $195.29M | -38.2% |
| 2021 | Dec 31, 2021 | $316.13M | -27.6% |
| 2020 | Dec 31, 2020 | $436.55M | – |
See a number that looks wrong?